Table 2.
Concentration of amino acids in the tumors. Data is shown as mean difference of treated and untreated samples in a 95% (CI) and standard error (SE); n = 9.
Amino acid | Mean difference (g/kg) at 95% CI |
SE | ||
---|---|---|---|---|
CDDP vs. Untreated | PtNPs-10 vs. Untreated | PtNPs-40 vs. Untreated | ||
Asp | -2.84 (-4.59 to -1.09)∗∗∗ | -0.22 (-1.97 to 1.52) | -0.48 (-2.23 to 1.27) | 0.64 |
Thr | -1.03 (-1.44 to -0.62)∗∗∗ | -0.29 (-0.70 to 0.11) | -0.50 (-0.91 to -0.09)∗ | 0.15 |
Ser | -1.19 (-1.74 to -0.63)∗∗∗ | -0.23 (-0.78 to 0.33) | -1.09 (-1.64 to -0.53)∗∗∗ | 0.20 |
Glu | -3.70 (-6.02 to -1.37)∗∗∗ | -0.28 (-2.61 to 2.04) | -0.61 (-2.94 to 1.71) | 0.86 |
Pro | -1.56 (-3.42 to 0.30) | -0.86 (-2.72 to 1.00) | 0.31 (-1.55 to 2.17) | 0.69 |
Gly | -1.95 (-3.16 to -0.73)∗∗∗ | -0.76 (-1.98 to 0.45) | 0.10 (-1.11 to 1.31) | 0.45 |
Ala | -1.62 (-2.87 to -0.36)∗∗ | -0.22 (-1.47 to 1.03) | 0.06 (-1.19 to 1.31) | 0.46 |
Cys | -0.21 (-0.41 to -0.01)∗ | −0.21 (-0.41 to -0.01)∗ | -0.05 (-0.25 to 0.16) | 0.07 |
Val | -1.90 (-2.94 to -0.85)∗∗∗ | -0.35 (-1.39 to 0.70) | -0.34 (-1.39 to 0.71) | 0.39 |
Met | -0.52 (-0.78 to -0.27)∗∗∗ | -0.11 (-0.37 to 0.14) | -0.21 (-0.47 to 0.04) | 0.10 |
Ile | -1.12 (-1.86 to -0.38)∗∗ | 0.08 (-0.66 to 0.82) | -0.16 (-0.91 to 0.58) | 0.27 |
Leu | -2.51 (-4.01 to -1.01)∗∗∗ | -0.41 (-1.91 to 1.09) | -0.97 (-2.47 to 0.53) | 0.55 |
Tyr | -1.07 (-1.64 to -0.49)∗∗∗ | -0.19 (-0.77 to 0.39) | -0.25 (-0.83 to 0.32) | 0.21 |
Phe | -1.21 (-2.17 to -0.25)∗∗ | -0.11 (-1.07 to 0.85) | -0.07 (-1.03 to 0.89) | 0.35 |
His | -0.82 (-1.18 to -0.45)∗∗∗ | -1.87 (-2.24 to -1.50)∗∗∗ | -1.73 (-2.10 to -1.36)∗∗∗ | 0.14 |
Lys | -2.44 (-4.72 to -0.17)∗ | 0.82 (-1.45 to 3.10) | 1.34 (-0.93 to 3.62) | 0.84 |
Arg | -3.10 (-6.48 to 0.29) | 1.36 (-2.03 to 4.74) | 3.87 (0.49–7.26)∗ | 1.25 |
Negative sign in front of the mean indicates a decrease in the concentration of the amino acid in the treated sample compared to the control.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.